Followers | 15 |
Posts | 892 |
Boards Moderated | 0 |
Alias Born | 04/28/2018 |
Monday, October 14, 2024 11:03:17 AM
Recent NVCR News
- Novocure to Participate in Upcoming Investor Conferences • Business Wire • 11/27/2024 12:00:00 PM
- Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma • Business Wire • 11/21/2024 12:05:00 PM
- FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma • Business Wire • 11/21/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 09:27:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:32:28 PM
- Novocure présente ses résultats financiers pour le troisième trimestre 2024 • Business Wire • 10/31/2024 02:36:00 PM
- Novocure meldet Finanzergebnisse des dritten Quartals 2024 • Business Wire • 10/31/2024 02:36:00 PM
- ノボキュア、2024年度第3四半期の決算を発表 • Business Wire • 10/31/2024 02:36:00 PM
- ノボキュア、クリストフ・ブラクマン氏を最高財務責任者(CFO)に任命 • Business Wire • 10/31/2024 11:07:00 AM
- Novocure nomme Christoph Brackmann au poste de directeur financier • Business Wire • 10/31/2024 11:07:00 AM
- Novocure ernennt Christoph Brackmann zum Finanzvorstand • Business Wire • 10/31/2024 03:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 11:02:07 AM
- Novocure Appoints Christoph Brackmann as Chief Financial Officer • Business Wire • 10/30/2024 11:02:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 11:00:29 AM
- Novocure Reports Third Quarter 2024 Financial Results • Business Wire • 10/30/2024 11:00:00 AM
- FDA genehmigt Optune Lua® von Novocure zur Behandlung des metastasierenden nicht-kleinzelligen Lungenkarzinoms • Business Wire • 10/22/2024 05:00:00 AM
- ノボキュアのOptune Lua®、転移性非小細胞肺がんの治療用としてFDAの承認を取得 • Business Wire • 10/20/2024 10:00:00 PM
- FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer • Business Wire • 10/15/2024 08:43:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 08:05:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 10:21:49 PM
- Novocure to Report Third Quarter 2024 Financial Results • Business Wire • 10/01/2024 11:00:00 AM
- Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy • Business Wire • 09/09/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:00:17 AM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM
BNCM Announces its Q3 and 9-Month Growth Results for 2024 • BNCM • Nov 26, 2024 7:03 AM
FoodTech Trailblazer Beyond Oil Appoints New COO from KFC Amidst Massive Global Expansion (OTCQB: BEOLF) (CSE: BOIL), up 250% this year • BOIL • Nov 25, 2024 11:12 AM
UC Asset announces plan of acquisition to increase awareness for its stock trading • UCASU • Nov 25, 2024 9:30 AM